Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) represents the most common arrhythmia leading to increased morbidity and mortality, yet, current treatment strategies have proven inadequate. Conventional treatment with antiarrhythmic drugs carries a high risk for proarrhythmias. The soluble epoxide hydrolase en...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Circ Arrhythm Electrophysiol
Autori principali: Sirish, Padmini, Li, Ning, Timofeyev, Valeriy, Zhang, Xiao-Dong, Wang, Lianguo, Yang, Jun, Lee, Kin Sing S., Bettaieb, Ahmed, Ma, Sin Mei, Lee, Jeong Han, Su, Demetria, Lau, Victor C., Myers, Richard E., Lieu, Deborah K., López, Javier E., Young, J. Nilas, Yamoah, Ebenezer N., Haj, Fawaz, Ripplinger, Crystal M., Hammock, Bruce D., Chiamvimonvat, Nipavan
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869994/
https://ncbi.nlm.nih.gov/pubmed/27162031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.115.003721
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi